Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
- PMID: 32895293
- PMCID: PMC7476419
- DOI: 10.1136/openhrt-2020-001350
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
Erratum in
-
Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.Open Heart. 2020 Oct;7(2):e001350corr1. doi: 10.1136/openhrt-2020-001350corr1. Open Heart. 2020. PMID: 33067346 Free PMC article. No abstract available.
Keywords: anti-oxidants; inflammation; oxidative stress.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors.Open Heart. 2021 Apr;8(1):e001655. doi: 10.1136/openhrt-2021-001655. Open Heart. 2021. PMID: 33875563 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources